Need Help?

Whole-exome sequencing (WES) data from a classical Hodgkin lymphoma patient obtained before pembrolizumab treatment and at relapse

This dataset contains raw paired-end whole-exome sequencing (WES) FASTQ files generated from plasma-derived cell-free DNA (cfDNA) collected from a patient with classical Hodgkin lymphoma before pembrolizumab treatment and at the time of relapse, together with a matched normal sample. Libraries were prepared using a whole-exome capture kit and sequenced on the Element AVITI platform to generate 2 × 150 bp paired-end reads. The submitted data comprise the primary sequencing output in gzipped FASTQ format.

Request Access

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000001985 Exome Sequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00009222495 bam 25.5 GB
EGAF00009222501 bam 31.1 GB
EGAF00009222521 bam 29.7 GB
3 Files (86.3 GB)